Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

DOJ sues Walgreens for allegedly filling ‘millions’ of illegal prescriptions

Walgreens filed a countersuit, accusing the federal government of failing to take down prescribers acting unlawfully. 

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures. 

Medicare Advantage Part C clipboard payment

Another insurer sues CMS over star ratings, citing contractor error

Alignment Health is accusing CMS and a third-party contractor of surveying Spanish-speaking members in English and using an "arbitrary" calculation method to reduce the ratings of Medicare Advantage plans.

money maze payment reimbursement

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

Federal Trade Comission FTC Sign logo

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated. 

Thumbnail

DEA wants to permanently anchor some COVID-era prescription regulations

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17. 

Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.

FDA regulator examines AI's growing influence in cardiology

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

money dollar benjamin cash finance graph chart deal dollar

Congressional Medicare advisors recommend tying radiologist pay increases to inflation

The American Medical Association this week criticized cuts to physician pay, while Medicare Advantage plans are slated to see a 4.33% boost.